Long-term Clinical Outcomes of Splanchnic Vein Thrombosis

2015223 citationsJournal Articlegreen Open Access

Authors

Walter Ageno · University of Insubria

Nicoletta Riva · University of Insubria

Sam Schulman · McMaster University

Jan Beyer‐Westendorf · University Hospital Carl Gustav Carus

Soo‐Mee Bang · Seoul National University

Marco Senzolo · University of Padua

Elvira Grandone ·

Abstract

Most patients with SVT have a substantial long-term risk of thrombotic events. In patients with cirrhosis, this risk must be balanced against a similarly high risk of major bleeding. Anticoagulant treatment appears to be safe and effective in most patients with SVT.

Topics & Keywords

Venous Thromboembolism Diagnosis and Management Central Venous Catheters and Hemodialysis Atrial Fibrillation Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Internal Medicine

Volume 175, Issue 9, pp. 1474-1474

DOI: 10.1001/jamainternmed.2015.3184

Field-Weighted Citation Impact: 20.74